Endocrine Abstracts

IntroductionFahr’s syndrome (FS) is a rare neurodegenerative disorder. It’s characterized by abnormal calcifications in basal ganglia and cerebral cortex inducing neuropsychiatric disorders and cognitive impairment. The aim of our study was to assess the prevalence of FS, its characteristics, and its associated factors in patients with permanent hypoparathyroidism.MethodsWe conducted a cross-section...

Introduction: Cardiovascular diseases are frequent in patients with hypopituitarism receiving conventional hormone replacement therapy. They represent the main cause of premature death in this population. Emerging evidence smggests that beyond traditional risk factors, evaluating coronary calcium score (CCS) and inflammatory markers such as high-sensitivity C-reactive protein (hs-CRP) provides valuable insights into cardiovascular health in this population. The aims of the pre...

Introduction: Thyroid cancer remains a relatively rare entity. Radiological scoring systems aim to stratify the risk of malignancy based on morphological criteria.The objective of this study was to develop a new score based on ultrasound criteria to predict thyroid nodule malignancy risk.Patients and methods: This was a retrospective study including 200 thyroid nodules (100 malignant nodules and 100 benign nodules). The report of the thyroid ultrasound a...

Introduction: Polycystic ovary syndrome is the most common cause of anovulatory infertility in women. Anti-Mullerian Hormone (AMH) was considered a reliable marker for the diagnosis of polycystic ovary syndrome (PCOS). However, AMH level is influenced by age and body mass index. The aim of this study was to analyze the performance of the (LH x AMH)/FSH ratio in the diagnosis of PCOS in women with morbid obesity.Methods: This was a cross-sectional study i...

Introduction: Obesity related disease complications reduce life quality and expectancy and increase health care costs. Non-alcoholic fatty liver disease (NAFLD) is one of the major complications associated with obesity and is considered to be the hepatic manifestation of the metabolic syndrome. Our objective was to determine the prevalence of the NAFLD and to identify its clinical and biological associated factors in women with morbid obesity.Methods: Th...

Background: Obesity is significantly associated to several reproductive disorders in women. However, the molecular mechanisms involved in this association are complex and still not completely understood. The aim of our study was to determine the prevalence of reproductive disturbances in a group of women with morbid obesity.Methods: We conducted a cross sectional study in 50 women with a body mass index (BMI) ≥40 kg/m2 collected in the e...

Background: Obesity is an increasingly common health problem which has been found to affect female reproductive function in several aspects. The aim of our study was to determine the ovarian ultrasound features in women with morbid obesity.Methods: We performed a cross sectional study in 50 women with a body mass index (BMI) ≥40 kg /m2 collected over a period of 6 months (October 2017–March 2018). For each woman, a sus-pubic ultraso...

Introduction: Visceral fat area (VFA) represents the amount of fat stored in the abdominal cavity around internal organs. It is increasingly recognized as a crucial marker of metabolic health and cardiovascular risk. The aims of the present study were to measure VFA and to assess its associated factors in women with complete anterior hypopituitarism.Methods: We conducted a cross-sectional study including 50 patients with a complete anterior hypopituitari...

Introduction: Polycystic ovary syndrome (PCOS) is a common disorder in women. Hyperandrogenism and chronic oligo-anovulation are the prominent clinical features. The aim of our study was to determine the prevalence and the predictive factors of PCOS in a group of women with morbid obesity.Methods: We performed a cross sectional study in 50 women with a body mass index (BMI) ≥ 40 kg /m2 collected over a period of 6 months (October 2017&#1...

Introduction: The level of anti-Mullerian hormone (AMH) is considered by several authors as a marker of polycystic ovary syndrome (PCOS). However, data are lacking regarding the real role of AMH and its cut-off value for predicting the existence of PCOS in women with morbid obesity.The aim of this study was to analyze the performance of the AMH assay in the diagnosis of PCOS in women with morbid obesity.Patients and Methods: We con...